Eisai’s Small Molecule Analog Reduced Inflammation and Injury in Mice with IBD, Study Shows

Eisai’s Small Molecule Analog Reduced Inflammation and Injury in Mice with IBD, Study Shows
A small molecule analog developed by Eisai, called ER-464195-01,  may be a potential therapy for patients with inflammatory bowel disease (IBD) by reducing infiltration of inflammatory cells, according to researchers. Their study, “Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease,” was published in the journal Nature Communications. IBD is

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *